# OnCo record paper-konoplya-academic-cd19-car-t-lymphoma-belarus-front-oncol-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-konoplya-academic-cd19-car-t-lymphoma-belarus-front-oncol-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-konoplya-academic-cd19-car-t-lymphoma-belarus-front-oncol-2026" ;
  schema:name "Academic CD19 CAR T-cell therapy for relapsed B-cell lymphoma at Belarus's national cancer centre"@en ;
  schema:description "Seventy-six people with relapsed or refractory B-cell lymphoma treated at the N.N. Alexandrov National Cancer Centre with an academic, non-commercial CAR T-cell product had a 57.5% complete response rate, and 67% were alive at four years."@en ;
  schema:url <https://onco.cc/key-papers/paper-konoplya-academic-cd19-car-t-lymphoma-belarus-front-oncol-2026/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  schema:citation <https://doi.org/10.3389/fonc.2026.1862517>, <https://pubmed.ncbi.nlm.nih.gov/42539439/>, <https://clinicaltrials.gov/study/NCT07524816> ;
  schema:sameAs <https://doi.org/10.3389/fonc.2026.1862517> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Konoplya NE, Doroshenko TM, Zharkova KY, et al." ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/follicular-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:institutions <https://onco.cc/institutions/alexandrov-national-cancer-centre-belarus/> .
